Nils Rehmann
Algemeen Directeur bij Canuevo Biotech, Inc.
Profiel
Nils Rehmann is the founder and currently serves as the Chief Executive Officer at Canuevo Biotech, Inc. which is founded in 2017.
He previously worked as the Director & Chief Science Officer at AREV Life Sciences Global Corp.
Dr. Rehmann holds a doctorate degree from University College Dublin and an undergraduate degree from Hochschulen Fresenius Gemeinnützige Traegergesellschaft mbH.
Actieve functies van Nils Rehmann
Bedrijven | Functie | Begin |
---|---|---|
Canuevo Biotech, Inc.
Canuevo Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Canuevo Biotech, Inc is a pharmaceutical development company. It produces natural health products and develops fully trialled pharmaceuticals to alleviate patients conditions and facilitate a life without negative side effects. The company was founded in 2017 and is headquartered Fredericton, Canada. | Algemeen Directeur | 01-01-2017 |
Eerdere bekende functies van Nils Rehmann
Bedrijven | Functie | Einde |
---|---|---|
AREV LIFE SCIENCES GLOBAL CORP. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Nils Rehmann
University College Dublin | Doctorate Degree |
Hochschulen Fresenius Gemeinnützige Traegergesellschaft mbH | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
AREV LIFE SCIENCES GLOBAL CORP. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Canuevo Biotech, Inc.
Canuevo Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Canuevo Biotech, Inc is a pharmaceutical development company. It produces natural health products and develops fully trialled pharmaceuticals to alleviate patients conditions and facilitate a life without negative side effects. The company was founded in 2017 and is headquartered Fredericton, Canada. | Commercial Services |